Transplant News and Research

RSS

New hydrosurgery system may help manage excessive bleeding during surgery

Carnegie Mellon University's Matt Oberdier is developing a new hydrosurgery system to help physicians better manage excessive bleeding during surgery.

15 Mar 2010

Growing incidence of chronic kidney disease: Early detection and knowledge of treatment options vital

As the incidence of diabetes and hypertension continues to grow worldwide – and increasing numbers of patients progressing to kidney disease and kidney failure place a financial strain on public health systems – the need for early patient education about kidney disease and treatment options, including home-based treatments, has become critical.

From Baxter International Inc. 12 Mar 2010

Investigators develop new mathematical approach to analyze molecular data

Investigators have developed a new mathematical approach to analyze molecular data derived from complex mixtures of immune cells. This approach, when combined with well-established techniques, readily identifies changes in small samples of human whole blood, and has the potential to distinguish between health and disease states.

11 Mar 2010

Platelet dosage can be lowered in transfusions for cancer and bone-marrow transplant patients

Physicians may be able to safely lower the platelet dosage in transfusions for cancer and bone-marrow transplant patients without risking increased bleeding, according to new research involving UT Southwestern Medical Center and 28 other medical institutions.

11 Mar 2010

Mayo Clinic to form new permanent professorship for cancer research

Mayo Clinic is forming a new permanent professorship to augment cancer research that will focus on finding new treatments and preventive measures to reduce the incidence of cancer.

11 Mar 2010

Positive results from Limerick BioPharma's LIM-0705 Phase 1a trial

Limerick BioPharma, Inc., a developer of innovative therapies that help cells pump unwanted or toxic substances away from vulnerable tissues, has announced positive results of a Phase 1a trial for its lead compound, LIM-0705, which has completed its first in man study.

10 Mar 2010

Skin transplant surgery safe and effective for treating vitiligo

In the first study of its kind in the United States, Henry Ford Hospital showed that skin transplant surgery is safe and effective for treating vitiligo.

10 Mar 2010

Chimerix initiates CMX001 Phase 2 clinical trial in stem cell transplant patients for CMV

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced the initiation of a multi-center Phase 2 clinical trial designed to evaluate CMX001 in stem cell transplant recipients who are seropositive for cytomegalovirus (CMV).

9 Mar 2010

Surgeons complete first phase of certification training to implant temporary CardioWest Total Artificial Heart

On March 4 & 5, the surgical team from the Onassis Cardiac Surgery Center, led by Dr. Petros Sfirakis, Director of the Transplantation Department & Mechanical Support Unit and Dr. Louis Louca, Surgeon/VAD Coordinator, completed the first phase of certification training to implant the SynCardia temporary CardioWest™ Total Artificial Heart.

9 Mar 2010

Orthofix International announces sale of vascular business assets to Covidien

Orthofix International N.V. announced today it has sold the assets of its vascular business, including its AV-Impulse® mechanical compression technology, to Covidien.

9 Mar 2010

Necessity of repeat biopsy in suspected prostate cancer: Gen-Probe's PROGENSA PCA3 assay can help determine

Gen-Probe's PROGENSA® PCA3 assay can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy, according to data from the two largest studies to date of the molecular urine test. The studies were presented last week at the American Society of Clinical Oncology's (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco.

8 Mar 2010

Scientists devise software algorithm to detect medically useful information from whole-blood samples

Scientists at the Stanford University School of Medicine have devised a software algorithm that could enable a common laboratory device to virtually separate a whole-blood sample into its different cell types and detect medically important gene-activity changes specific to any one of those cell types.

8 Mar 2010

Liver transplantation specialists form guidelines for allocation of organs for patients with HCC

Liver transplantation specialists recently convened to address U.S. guidelines for allocation of organs for patients with hepatocellular carcinoma (HCC, liver cancer). Representatives from more than 130 U.S. transplant centers were invited to the conference and participants included 180 leaders in liver transplantation (LT) from the 50 most active centers.

5 Mar 2010

DUSA Pharmaceuticals to unveil BLU-U Blue Light Photodynamic Therapy Illuminator at AAD meeting

DUSA Pharmaceuticals, Inc.®, a specialty pharmaceutical company focused on dermatology, will unveil an ergonomically enhanced BLU-U® Blue Light Photodynamic Therapy Illuminator at this year's American Academy of Dermatology meeting in Miami, Florida, March 5-9. BLU-U, in conjunction with the Levulan® Kerastick® topical treatment, is an integral part of the Levulan® Photodynamic Therapy (PDT) technology platform.

5 Mar 2010

Dialysis patients gather to encourage state lawmakers to support Medigap legislation

More than 50 dialysis patients, family members and kidney care advocates from across South Carolina gathered at the state Capitol today with the National Kidney Foundation Serving the Carolinas, South Carolina Region (NKF) and Dialysis Patient Citizens (DPC) to encourage state lawmakers to support Medigap legislation (S. 1128, sponsored by Senators Harvey Peeler (R-Cherokee) and Phillip Shoopman (R-Greenville), and H. 4552, sponsored by Representatives Joan Brady (R-Richland), Bill Sandifer (R-Seneca) and Kristopher Crawford (R-Florence)).

5 Mar 2010

Porter Adventist Hospital designated as Blue Distinction Center for spine surgery, knee and hip replacement programs

Porter Adventist Hospital is among the first in the country to receive designation as Blue Distinction Centers in two surgical services that have recently been added to the Blue Cross and Blue Shield Association's expansion of its Blue Distinction® designation.

5 Mar 2010

Endothelial cells can produce copious amounts of adult stem cells: Study

In a leap toward making stem cell therapy widely available, researchers at the Ansary Stem Cell Institute at Weill Cornell Medical College have discovered that endothelial cells, the most basic building blocks of the vascular system, produce growth factors that can grow copious amounts of adult stem cells and their progeny over the course of weeks.

5 Mar 2010

TransMedics closes $36M financing round

TransMedics, Inc., a leading medical device company focusing on delivering the next standard of care for solid organ transplantation worldwide, announced today the closing of a $36 million financing round. The financing was lead by Foundation Capital and Kleiner Perkins Caufield & Byers (KPCB) and also included investments by Flagship Ventures and by several existing investors.

5 Mar 2010

Risk of MS increases by many folds following infection with EBV: Study

Researchers from the Harvard School of Public Health, Walter Reed Army Institute of Research, and a team of collaborators have observed for the first time that the risk of multiple sclerosis (MS) increases by many folds following infection with the Epstein-Barr virus (EBV).

5 Mar 2010

Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs

Diplomat Specialty Pharmacy, the nation's largest privately held specialty pharmacy company, is on a mission to help patients obtain the financial assistance they need to purchase life-saving drugs for such illnesses as cancer, HIV/AIDS and Hepatitis C, as well as drugs for Multiple Sclerosis, kidney disease and other chronic conditions.

4 Mar 2010

Transplant News and Research

New hydrosurgery system may help manage excessive bleeding during surgery

Growing incidence of chronic kidney disease: Early detection and knowledge of treatment options vital

Investigators develop new mathematical approach to analyze molecular data

Platelet dosage can be lowered in transfusions for cancer and bone-marrow transplant patients

Mayo Clinic to form new permanent professorship for cancer research

Positive results from Limerick BioPharma's LIM-0705 Phase 1a trial

Skin transplant surgery safe and effective for treating vitiligo

Chimerix initiates CMX001 Phase 2 clinical trial in stem cell transplant patients for CMV

Surgeons complete first phase of certification training to implant temporary CardioWest Total Artificial Heart

Orthofix International announces sale of vascular business assets to Covidien

Necessity of repeat biopsy in suspected prostate cancer: Gen-Probe's PROGENSA PCA3 assay can help determine

Scientists devise software algorithm to detect medically useful information from whole-blood samples

Liver transplantation specialists form guidelines for allocation of organs for patients with HCC

DUSA Pharmaceuticals to unveil BLU-U Blue Light Photodynamic Therapy Illuminator at AAD meeting

Dialysis patients gather to encourage state lawmakers to support Medigap legislation

Porter Adventist Hospital designated as Blue Distinction Center for spine surgery, knee and hip replacement programs

Endothelial cells can produce copious amounts of adult stem cells: Study

TransMedics closes $36M financing round

Risk of MS increases by many folds following infection with EBV: Study

Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News